Elsevier

Journal of Infection

Volume 86, Issue 2, February 2023, Pages 154-225
Journal of Infection

Letter to the Editor
There is no reasonable evidence to support efficacy of fluvoxamine in prevention of disease deterioration in COVID-19 outpatients: A comment on two recent meta-analyses advocating its use

https://doi.org/10.1016/j.jinf.2022.11.016Get rights and content

Cited by (0)

View Abstract